WO2005084254A3 - Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription - Google Patents

Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription Download PDF

Info

Publication number
WO2005084254A3
WO2005084254A3 PCT/US2005/006292 US2005006292W WO2005084254A3 WO 2005084254 A3 WO2005084254 A3 WO 2005084254A3 US 2005006292 W US2005006292 W US 2005006292W WO 2005084254 A3 WO2005084254 A3 WO 2005084254A3
Authority
WO
WIPO (PCT)
Prior art keywords
reverse transcription
specific primers
rna
panel
truncated gene
Prior art date
Application number
PCT/US2005/006292
Other languages
French (fr)
Other versions
WO2005084254A2 (en
Inventor
Michael Mitas
David J Cole
William E Gillanders
Kaidi Mikhitarian
Original Assignee
Musc Found For Res Dev
Michael Mitas
David J Cole
William E Gillanders
Kaidi Mikhitarian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Musc Found For Res Dev, Michael Mitas, David J Cole, William E Gillanders, Kaidi Mikhitarian filed Critical Musc Found For Res Dev
Priority to US10/590,891 priority Critical patent/US7981616B2/en
Publication of WO2005084254A2 publication Critical patent/WO2005084254A2/en
Publication of WO2005084254A3 publication Critical patent/WO2005084254A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Abstract

The present invention provides truncated gene-specific primers in panels that can be used during the reverse transcription step of RT-PCR to increase signal detection of cancer gene markers in a tissue sample. Also provided are forward and reverse primers for RT­-PCR. Methods of using the primers are also provided.
PCT/US2005/006292 2004-02-27 2005-02-25 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription WO2005084254A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/590,891 US7981616B2 (en) 2004-02-27 2005-02-25 Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54855204P 2004-02-27 2004-02-27
US60/548,552 2004-02-27

Publications (2)

Publication Number Publication Date
WO2005084254A2 WO2005084254A2 (en) 2005-09-15
WO2005084254A3 true WO2005084254A3 (en) 2006-08-10

Family

ID=34911005

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/006292 WO2005084254A2 (en) 2004-02-27 2005-02-25 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
PCT/US2005/006067 WO2005082041A2 (en) 2004-02-27 2005-02-28 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2005/006067 WO2005082041A2 (en) 2004-02-27 2005-02-28 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription

Country Status (2)

Country Link
US (1) US7981616B2 (en)
WO (2) WO2005084254A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138716A2 (en) * 2005-06-17 2006-12-28 Brt Laboratories, Inc. Thermodynamically defined gene specific primers
WO2013010074A1 (en) 2011-07-13 2013-01-17 Primeradx, Inc. Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
CA2877864C (en) * 2012-06-28 2019-05-14 James Douglas Watson Targeted rna-seq methods and materials for the diagnosis of prostate cancer
JP7184373B2 (en) * 2020-01-29 2022-12-06 学校法人九州文化学園 Ex vivo test method for intestinal tumor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801016A (en) * 1995-03-29 1998-09-01 Japan Tobacco Inc. DNA fragment, recombinant vector containing the same and method for expressing foreign genes using the same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US616952A (en) * 1899-01-03 Detachable hinge
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6346413B1 (en) * 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
EP0519338B1 (en) * 1991-06-20 1996-08-28 F. Hoffmann-La Roche Ag Improved methods for nucleic acid amplification
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
EP1350514A3 (en) 1993-10-29 2004-07-07 The Brigham And Women's Hospital, Inc. Therapeutic use of cis-element decoys in vivo
US5773213A (en) * 1994-06-06 1998-06-30 Brigham & Women's Hospital Method for conducting sequential nucleic acid hybridization steps
DE69632870T2 (en) * 1995-03-17 2005-07-14 John Wayne Cancer Institute, Santa Monica DETECTION OF MELANOMA MEASURING TASTES USING MULTILARMARKER TEST
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
CN1151269C (en) * 1995-06-06 2004-05-26 扬·维吉 Method of and apparatus for diagnostic DNA testing
US5882856A (en) * 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
AUPO188396A0 (en) 1996-08-26 1996-09-19 Insearch Limited Detection of protozoan parasites
US5958349A (en) * 1997-02-28 1999-09-28 Cepheid Reaction vessel for heat-exchanging chemical processes
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
US6440725B1 (en) 1997-12-24 2002-08-27 Cepheid Integrated fluid manipulation cartridge
GB9719044D0 (en) 1997-09-08 1997-11-12 Inst Of Ophthalmology Assay
US6660228B1 (en) 1998-03-02 2003-12-09 Cepheid Apparatus for performing heat-exchanging, chemical reactions
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6306643B1 (en) * 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6245517B1 (en) * 1998-09-29 2001-06-12 The United States Of America As Represented By The Department Of Health And Human Services Ratio-based decisions and the quantitative analysis of cDNA micro-array images
US6431476B1 (en) 1999-12-21 2002-08-13 Cepheid Apparatus and method for rapid ultrasonic disruption of cells or viruses
EP1146869A2 (en) 1999-01-27 2001-10-24 University Of South Florida Inhibition of stat3 signal transduction for human cancer therapy
US6251601B1 (en) * 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
US6300069B1 (en) 1999-05-03 2001-10-09 Qiagen Gmbh Generation and amplification of nucleic acids from ribonucleic acids
ATE278771T1 (en) 1999-05-28 2004-10-15 Cepheid APPARATUS AND METHOD FOR ANALYZING LIQUID SAMPLES
ATE333938T1 (en) 1999-05-28 2006-08-15 Cepheid CARTRIDGE FOR PERFORMING A CHEMICAL REACTION
SE9902410D0 (en) 1999-06-24 1999-06-24 Cavidi Tech Ab Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples
US6403037B1 (en) 2000-02-04 2002-06-11 Cepheid Reaction vessel and temperature control system
US6783934B1 (en) 2000-05-01 2004-08-31 Cepheid, Inc. Methods for quantitative analysis of nucleic acid amplification reaction
US8048386B2 (en) 2002-02-25 2011-11-01 Cepheid Fluid processing and control
US6374684B1 (en) 2000-08-25 2002-04-23 Cepheid Fluid control and processing system
US6312929B1 (en) 2000-12-22 2001-11-06 Cepheid Compositions and methods enabling a totally internally controlled amplification reaction
US7101663B2 (en) 2001-03-02 2006-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education PCR method
JPWO2003055973A1 (en) 2001-12-26 2005-05-12 オリンパス株式会社 Reaction vessel and reaction vessel holding mechanism
US6819027B2 (en) 2002-03-04 2004-11-16 Cepheid Method and apparatus for controlling ultrasonic transducer
US20040101859A1 (en) 2002-11-25 2004-05-27 Cepheid Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
US7824857B2 (en) 2003-12-02 2010-11-02 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801016A (en) * 1995-03-29 1998-09-01 Japan Tobacco Inc. DNA fragment, recombinant vector containing the same and method for expressing foreign genes using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 27 October 1999 (1999-10-27), CZYGAN ET AL.: "Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatre disorders", Database accession no. (AJ246858.1) *
INFECT. DIS., vol. 180, no. 5, 1999, pages 1695 - 1699 *

Also Published As

Publication number Publication date
WO2005082041A2 (en) 2005-09-09
WO2005082041A3 (en) 2009-06-11
WO2005084254A2 (en) 2005-09-15
US20080233563A1 (en) 2008-09-25
US7981616B2 (en) 2011-07-19

Similar Documents

Publication Publication Date Title
WO2008092016A3 (en) Methods, compositions, and kits for detection of micro rna
WO2006037462A3 (en) Cancer markers
WO2008005675A3 (en) Emulsion pcr and amplicon capture
WO2010054108A8 (en) Cas6 polypeptides and methods of use
IL183088A0 (en) Inhibitors of 11-?? hydroxyl steroid dehydrogenase type 1 and methods of using the same
WO2009009432A3 (en) Recurrent gene fusions in prostate cancer
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2010059702A3 (en) Recurrent gene fusions in prostate cancer
WO2005034845A3 (en) Compositions and methods for treatment of cancer
WO2004027025A3 (en) Helicase dependent amplification of nucleic acids
WO2011053790A3 (en) Assay of closely linked genetic targets in fetal diagnosis
WO2007093657A3 (en) Method for the molecular diagnosis of prostate cancer and kit for implementing same
EP2120956A4 (en) Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
WO2009042186A3 (en) Genomic editing in zebrafish using zinc finger nucleases
WO2007136736A3 (en) Methods for nucleic acid sorting and synthesis
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
WO2009019368A3 (en) Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer
EP2046990A4 (en) Method of denaturing and fragmenting dna or rna using ultrasound
WO2008048673A3 (en) Sequences diagnostic for shrimp pathogens
WO2005082041A3 (en) Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
WO2006005081A3 (en) Compositions and methods for identifying nucleotides in polynucleotide sequences
EP2064658A4 (en) Relative threshold and use of edges in optical character recognition process
WO2010096660A3 (en) Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
AU2003228984A1 (en) Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
EP1953541A4 (en) Method for determination of amount of double-stranded dna and kit for the determination

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 10590891

Country of ref document: US